Dynavax Technologies Corp (NASDAQ:DVAX)

CAPS Rating: 3 out of 5

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

DVAX News and Commentary

Caps

How do you think DVAX will perform against the market?

Add Stock to CAPS Watchlist

All Players

208 Outperform
15 Underperform
 

All-Star Players

39 Outperform
5 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top DVAX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Patastic (22.44)
Submitted August 09, 2017

Heplisav Approval almost a lock. SD-101 shows great promise in combination with Keytruda (100% ORR). New lung cancer inhalable TLR agonist in combo with anti PD-1 going into trials this quarter. Partnership with AstraZeneca on a cure for… More

zzlangerhans (99.70)
Submitted November 14, 2016

The zzporte portfolio ate a large helping of dirt today with the announcement of the CRL for Heplisav. The CRL wasn't an enormous surprise, given the tortuous history of Heplisav and the cancellation of the Ad Comm. I probably wouldn't have bought… More

DVAX VS S&P 500 (SPY)

Fools bullish on DVAX are also bullish on:

Fools bearish on DVAX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about DVAX.

Recs

0
Member Avatar TMFGBudwell (50.86) Submitted: 12/18/2017 4:17:46 AM : Outperform Start Price: $19.40 DVAX Score: -15.17

Undervalued from a long-term growth perspective.

Recs

1
Member Avatar Patastic (22.44) Submitted: 8/9/2017 4:52:28 PM : Outperform Start Price: $16.25 DVAX Score: -6.90

Heplisav Approval almost a lock. SD-101 shows great promise in combination with Keytruda (100% ORR). New lung cancer inhalable TLR agonist in combo with anti PD-1 going into trials this quarter. Partnership with AstraZeneca on a cure for asthma...Holy cow. I'm in long on this one.

Recs

1
Member Avatar adamicius (< 20) Submitted: 3/22/2017 11:38:13 AM : Outperform Start Price: $5.75 DVAX Score: +175.22

promising oncology & hepatitis compounds pipeline.

Leaderboard

Find the members with the highest scoring picks in DVAX.

Score Leader

Under5

Under5 (37.71) Score: +301.19

The Score Leader is the player with the highest score across all their picks in DVAX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 37.71 2/10/2017 Outperform 5Y $4.00 +318.75% +17.56% +301.19 0 Comment
stereotyp72 75.30 1/24/2017 Outperform 5Y $4.15 +303.61% +20.21% +283.41 0 Comment
SaintCroix 99.03 1/9/2017 Outperform 5Y $4.30 +289.53% +19.94% +269.60 0 Comment
rocknrook 61.14 1/19/2017 Outperform 3Y $4.30 +289.53% +20.23% +269.30 1 Comment
portefeuille 98.93 12/12/2016 Outperform 5Y $4.55 +268.13% +20.25% +247.88 0 Comment
mavimadero 36.44 10/9/2006 Underperform 3W $72.90 -77.02% +114.20% +191.22 0 Comment
hawkider 29.64 12/8/2006 Underperform 3Y $95.20 -82.41% +104.72% +187.13 1 Comment
BigDreamer 61.50 4/17/2017 Outperform NS $5.60 +199.11% +16.75% +182.36 0 Comment
ITTOG 76.98 5/30/2017 Outperform 1Y $5.75 +191.30% +12.77% +178.53 0 Comment
HondurasAlan 71.65 1/8/2007 Underperform 3W $61.40 -72.72% +104.49% +177.21 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRBCCapMkts 88.67 8/1/2017 Outperform NS $16.25 +3.08% +9.98% -6.90 0 Comment
TrackJimCramer 85.44 8/6/2015 Outperform 3W $27.74 -39.62% +30.62% -70.24 0 Comment
TrackJPMorgan 87.39 3/23/2015 Outperform NS $24.39 -31.32% +29.34% -60.66 0 Comment
TrackJimCramer 85.44 11/21/2014 Underperform 3W $14.29 +94.12% +0.81% -93.31 8/6/2015 @ $27.74 0 Comment
TrackJimCramer 85.44 9/14/2012 Outperform 3W $45.50 -68.59% +40.37% -108.96 11/21/2014 @ $14.29 0 Comment
TrackMLVCo < 20 1/4/2012 Outperform NS $32.70 +44.65% +8.44% +36.21 4/17/2012 @ $47.30 0 Comment
TrackZacks < 20 12/27/2010 Outperform 3M $30.40 +37.17% +9.96% +27.21 11/9/2012 @ $41.70 1 Comment
TrackJefferies 83.06 11/8/2010 Outperform NS $21.40 -21.73% +122.45% -144.18 0 Comment
TrackWedbush 88.92 5/13/2010 Outperform NS $20.40 -17.89% +132.35% -150.24 0 Comment
TrackSusquehanna 93.55 9/10/2009 Outperform NS $29.50 -43.22% +163.44% -206.66 0 Comment
TrackZacks < 20 2/20/2008 Outperform 3M $49.50 -55.56% -4.12% -51.44 3/19/2008 @ $22.00 1 Comment
TrackCreditSuiss 90.80 10/3/2007 Outperform NS $45.00 -62.78% +85.38% -148.16 0 Comment
trackmerriman 69.02 12/20/2006 Outperform NS $92.60 -73.00% -8.10% -64.90 3/18/2008 @ $25.00 0 Comment
TrackJMP 85.03 11/30/2006 Outperform NS $99.00 -46.67% +3.87% -50.53 2/26/2007 @ $52.80 0 Comment

Featured Broker Partners